Barret J, Chitayat D, Sermer M, Amankwah K, Morrow R, Toi A, Ryan G
University of Toronto, Ontario, Canada.
Prenat Diagn. 1995 Sep;15(9):849-53. doi: 10.1002/pd.1970150910.
The prenatal diagnosis of an echogenic fetal lung (EFL) is now often made in the early second trimester using high-resolution ultrasound. This ultrasound appearance is usually caused by a congenital cystic adenomatoid lung malformation (CCAM), an intrapulmonary lung sequestration or obstruction of a major airway. In order to provide prognostic guidelines to parents who may be considering termination of a fetus with these findings, we have analysed a series of 11 cases diagnosed in our centre over the past 2 years in conjunction with 60 cases from major published series. The data suggest that in the absence of non-immune hydrops fetalis (NIHF) or other anomalies, the outcome for the fetuses is excellent, with over 90 per cent survival. Neither early diagnosis (24 weeks) nor the presence of mediastinal shift is a poor prognostic indicator. In addition, it appears that if NIHF is absent at diagnosis, the chance that it will develop as the pregnancy continues is small (6 per cent). Furthermore, there is a significant (up to 30 per cent) chance that this ultrasound finding will resolve in utero. The development of in utero fetal surgical techniques may be the only hope for those hydropic fetuses who appear to have a dismal prognosis.
目前,在孕中期早期使用高分辨率超声常常能够对胎儿肺呈强回声(EFL)进行产前诊断。这种超声表现通常由先天性囊性腺瘤样肺畸形(CCAM)、肺内肺隔离症或主气道梗阻引起。为了给那些可能考虑终止患有这些病症胎儿妊娠的父母提供预后指导方针,我们分析了过去2年在我们中心诊断出的一系列11例病例,并结合主要已发表系列中的60例病例。数据表明,在没有胎儿非免疫性水肿(NIHF)或其他异常的情况下,胎儿的预后良好,存活率超过90%。早期诊断(24周)和纵隔移位的存在均不是不良预后指标。此外,似乎如果诊断时不存在NIHF,那么随着妊娠继续其出现的可能性很小(6%)。再者,这种超声表现有很大几率(高达30%)会在子宫内自行消失。对于那些预后似乎不佳的水肿胎儿而言,子宫内胎儿外科手术技术的发展可能是唯一的希望。